SIC
MRNA icon

Salem Investment Counselors’s Moderna MRNA Stock Holding History

Salem Investment Counselors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8K Hold
40
– – ﹤0.01% 1076
2026
Q1 		$2.03K Buy
+40
New +$1.87K ﹤0.01% 1079
2025
Q4 		– Sell
-55
Closed -$1.42K – 854
2025
Q3 		$1.42K Hold
55
– – ﹤0.01% 1100
2025
Q2 		$1.52K Hold
55
– – ﹤0.01% 1062
2025
Q1 		$1.56K Hold
55
– – ﹤0.01% 1069
2024
Q4 		$2.29K Sell
55
-154
-74% -$7.36K ﹤0.01% 1007
2024
Q3 		$14K Buy
209
+4
+2% +$367 ﹤0.01% 797
2024
Q2 		$24.3K Sell
205
-10
-5% -$1.26K ﹤0.01% 696
2024
Q1 		$22.9K Buy
215
+150
+231% +$15.1K ﹤0.01% 692
2023
Q4 		$6.46K Sell
65
-819
-93% -$68.9K ﹤0.01% 872
2023
Q3 		$91.3K Sell
884
-108
-11% -$12K ﹤0.01% 429
2023
Q2 		$121K Sell
992
-16
-2% -$2.13K ﹤0.01% 388
2023
Q1 		$155K Hold
1,008
– – 0.01% 368
2022
Q4 		$181K Buy
1,008
+24
+2% +$3.92K 0.01% 345
2022
Q3 		$116K Buy
984
+100
+11% +$15.2K 0.01% 375
2022
Q2 		$126K Hold
884
– – 0.01% 384
2022
Q1 		$152K Buy
884
+28
+3% +$4.71K 0.01% 373
2021
Q4 		$217K Buy
856
+12
+1% +$3.51K 0.01% 362
2021
Q3 		$325K Buy
844
+4
+0.5% +$1.48K 0.02% 288
2021
Q2 		$197K Buy
840
+250
+42% +$44.7K 0.01% 329
2021
Q1 		$77K Hold
590
– – ﹤0.01% 394
2020
Q4 		$62K Buy
+590
New +$59.7K ﹤0.01% 399

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Salem Investment Counselors's MRNA Position: Q2 2026 in Review

Salem Investment Counselors held its Moderna (MRNA) position steady in Q2 2026 at 40 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Salem Investment Counselors first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $325K in Q3 2021. 315 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Salem Investment Counselors held 40 shares of Moderna worth $2.8K as of Q2 2026.
  • Salem Investment Counselors left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1076 holding.
  • Salem Investment Counselors first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Salem Investment Counselors's Moderna position peaked at $325K in Q3 2021.
  • 315 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.